Rigel Pharma (RIGL) Tops Q4 EPS by 80c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $40.79 -2.58%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
OFLX, AFIB, NMRD, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.80. Revenue for the quarter came in at $57.6 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
